Gastric Bypass vs Diet and Cardiovascular Risk Factors
JAMA Surgery · 2024
DOI: 10.1001/jamasurg.2024.2162 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift JAMA Surgery, 2024. Verfasst von Cecilia Karlsson und 17 weiteren Autor:innen. Beteiligte Einrichtung: Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden. Hauptthemen laut MEDLINE: Caloric Restriction, Gastric Bypass, Heart Disease Risk Factors, Obesity, Morbid. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 40 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Importance Roux-en-Y gastric bypass (RYGB) is associated with reduced cardiovascular (CV) risk factors, morbidity, and mortality. Whether these effects are specifically induced by the surgical procedure or the weight loss is unclear.
Objective
To compare 6-week changes in CV risk factors in patients with obesity undergoing matching caloric restriction and weight loss by RYGB or a very low-energy diet (VLED). Design, Setting, and Participants This nonrandomized controlled study (Impact of Body Weight, Low Calorie Diet, and Gastric Bypass on Drug Bioavailability, Cardiovascular Risk Factors, and Metabolic Biomarkers [COCKTAIL]) was conducted at a tertiary care obesity center in Norway. Participants were individuals with severe obesity preparing for RYGB or a VLED. Recruitment began February 26, 2015; the first patient visit was on March 18, 2015, and the last patient visit (9-week follow-up) was on August 9, 2017. Data were analyzed from April 30, 2021, through June 29, 2023.
Interventions
VLED alone for 6 weeks or VLED for 6 weeks after RYGB; both interventions were preceded by 3-week LED. Main Outcomes and Measures Between-group comparisons of 6-week changes in CV risk factors.
Results
Among 78 patients included in the analyses, the mean (SD) age was 47.5 (9.7) years; 51 (65%) were women, and 27 (35%) were men. Except for a slightly higher mean (SD) body mass index of 44.5 (6.2) in the RYGB group (n = 41) vs 41.9 (5.4) in the VLED group (n = 37), baseline demographic and clinical characteristics were similar between groups. Major atherogenic blood lipids (low-density lipoprotein cholesterol, non–high-density lipoprotein cholesterol, apolipoprotein B, lipoprotein[a]) were reduced after RYGB in comparison with VLED despite a similar fat mass loss. Mean between-group differences were −17.7 mg/dL (95% CI, −27.9 to −7.5), −17.4 mg/dL (95% CI, −29.8 to −5.0) mg/dL, −9.94 mg/dL (95% CI, −15.75 to −4.14), and geometric mean ratio was 0.55 U/L (95% CI, 0.42 to 0.72), respectively. Changes in glycemic control and blood pressure were similar between groups. Conclusions and Relevance This study found that clinically meaningful reductions in major atherogenic blood lipids were demonstrated after RYGB, indicating that RYGB may reduce CV risk independent of weight loss. Trial Registration ClinicalTrials.gov Identifier: NCT02386917
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Late-Stage Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
- Department of Molecular and Clinical Medicine, Institute of Medicine, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.
- Department of Endocrinology, Obesity and Nutrition, Vestfold Hospital Trust, Tønsberg, Norway.
- Research and Early Development, Cardiovascular, Renal and Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
- The Lipid Clinic, Oslo University Hospital, Oslo, Norway.
- Department of Nutrition, Institute of Basic Medical Sciences, Faculty of Medicine, University of Oslo, Oslo, Norway.
Zitieren
APA
Karlsson, C., Johnson, L. K., Greasley, P. J., Retterstøl, K., Hedberg, J., Hall, M., Hawker, N., Robertsen, I., Havsol, J., Hertel, J. K., Sandbu, R., Skovlund, E., Olsen, T., Christensen, H., Jansson-Löfmark, R., Andersson, S., Åsberg, A., & Hjelmesæth, J. (2024). Gastric Bypass vs Diet and Cardiovascular Risk Factors. JAMA Surgery. https://doi.org/10.1001/jamasurg.2024.2162
Vancouver
Karlsson C, Johnson LK, Greasley PJ, Retterstøl K, Hedberg J, Hall M, et al. Gastric Bypass vs Diet and Cardiovascular Risk Factors. JAMA Surgery. 2024. doi:10.1001/jamasurg.2024.2162
BibTeX
@article{Karlsson2024,
author = {Karlsson, Cecilia and Johnson, Line Kristin and Greasley, Peter J and Retterstøl, Kjetil and Hedberg, Jonatan and Hall, Martin and Hawker, Noele and Robertsen, Ida and Havsol, Jesper and Hertel, Jens Kristoffer and Sandbu, Rune and Skovlund, Eva and Olsen, Thomas and Christensen, Hege and Jansson-Löfmark, Rasmus and Andersson, Shalini and Åsberg, Anders and Hjelmesæth, Jøran},
title = {Gastric Bypass vs Diet and Cardiovascular Risk Factors},
journal = {JAMA Surgery},
year = {2024},
doi = {10.1001/jamasurg.2024.2162}
}
EUVIMED